News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SR Pharma PLC (SPA.L) Granted Core RNAi Patent By European Patent Office


1/3/2007 6:27:17 PM

LONDON (AFX) - SR Pharma plc said the European Patent Office has granted the company its core RNAi patent for the company's compounds which form the basis of its therapeutic development pipeline focused on cancer indications.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES